SEC Form 4 · accession 0000899243-18-031839
Clovis Oncology, Inc. · CLVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Corwin Dale Hooks
Officer — See Remarks
Period of report
Aug 31, 2017
Accepted (ET)
Dec 27, 2018 · 4:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 31, 2017 | S | 2,150 | $76.36 | D | 19 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Senior Vice President and Chief Commercial Officer